NAZRA NUHMAN: Open Payments
NPI 1033589098 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| Exelixis Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: VENCLEXTA, ULTOMIRIS, IBRANCE, DARZALEX, PEMAZYRE, CABOMETYX, KEYTRUDA.
Industry payments across NC — which companies pay providers there.
